Xvivo Competitors

XVIPF Stock  USD 20.11  0.71  3.66%   
Xvivo Perfusion AB competes with PolyNovo, 4DMedical, CellaVision, Swedencare, and Viva Biotech; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Devices industry. Analyzing Xvivo Perfusion competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Xvivo Perfusion to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Xvivo Perfusion Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Xvivo Perfusion competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
17.2420.1122.98
Details
Intrinsic
Valuation
LowRealHigh
15.1017.9720.84
Details
Naive
Forecast
LowNextHigh
17.3420.2123.08
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.0918.3520.61
Details

Xvivo Perfusion Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Xvivo Perfusion and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Xvivo and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Xvivo Perfusion AB does not affect the price movement of the other competitor.

High positive correlations

CLVSFCALZF
SOLTFCALZF
SOLTFCLVSF
VBIZFCLVSF
VBIZFCALZF
AVNBFSWDCF
  

High negative correlations

BJTRFLBLTF
SOLTFAVNBF
AVNBFCALZF
AVNBFCLVSF
AVNBFVBIZF
SOLTFSWDCF

Risk-Adjusted Indicators

There is a big difference between Xvivo Pink Sheet performing well and Xvivo Perfusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xvivo Perfusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CALZF  1.63 (0.43) 0.00 (0.37) 0.00 
 5.88 
 22.71 
FDMDF  5.60  1.58  0.10 (1.39) 4.66 
 19.83 
 85.06 
CLVSF  0.40 (0.23) 0.00 (0.52) 0.00 
 0.00 
 13.43 
LBLTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SWDCF  1.00  0.11  0.00  0.21  0.00 
 2.74 
 33.37 
VBIZF  1.86  0.04  0.00  0.43  0.00 
 0.00 
 72.49 
AVNBF  1.37  0.63  0.00  0.86  0.00 
 0.00 
 40.17 
BJTRF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SOLTF  1.67 (0.37) 0.00 (0.96) 0.00 
 3.80 
 27.75 
FOGCF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Xvivo Perfusion Competitive Analysis

The better you understand Xvivo Perfusion competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Xvivo Perfusion's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Xvivo Perfusion's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
XVIPF CALZF FDMDF CLVSF LBLTF SWDCF VBIZF AVNBF BJTRF SOLTF
 3.66 
 20.11 
Xvivo
 10.71 
 0.75 
PolyNovo
 27.03 
 2.35 
4DMedical
 16.85 
 16.83 
CellaVision
 0.00 
 0.0001 
Lattice
 7.50 
 3.87 
Swedencare
 16.67 
 0.25 
Viva
 0.00 
 26.23 
Avon
 0.00 
 0.65 
Beijing
 3.35 
 4.91 
Sosei
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Xvivo Perfusion Competition Performance Charts

Five steps to successful analysis of Xvivo Perfusion Competition

Xvivo Perfusion's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Xvivo Perfusion AB in relation to its competition. Xvivo Perfusion's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Xvivo Perfusion in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Xvivo Perfusion's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Xvivo Perfusion AB, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Xvivo Perfusion position

In addition to having Xvivo Perfusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Robots And Drones Thematic Idea Now

Robots And Drones
Robots And Drones Theme
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Xvivo Pink Sheet

Xvivo Perfusion financial ratios help investors to determine whether Xvivo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xvivo with respect to the benefits of owning Xvivo Perfusion security.